HTLV-I (Human T-lymphotropic virus type 1) infection is a viral infection that attacks the CD4+ T-cells (a type of white blood cell) and can lead to the development of various diseases, including Adult T-cell Leukemia/Lymphoma (ATLL) and HTLV-I Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP). The virus is primarily transmitted through breastfeeding, sexual contact, or contaminated blood products. After infection, the virus becomes integrated into the host's DNA and can remain dormant for years, even decades, before leading to the development of disease. Most people infected with HTLV-I do not develop any symptoms, but a small percentage will go on to develop serious complications.

Deltaretroviruses are a genus of retroviruses that include human T-lymphotropic virus (HTLV) types 1 and 2, bovine leukemia virus (BLV), and simian T-lymphotropic viruses. Antibodies against deltaretroviruses are proteins produced by the immune system in response to an infection with one of these viruses.

Antibodies are formed when the immune system recognizes a foreign substance, such as a virus, as harmful. The immune system then produces specific proteins called antibodies to bind to and help neutralize or remove the foreign substance from the body. Detection of deltaretrovirus antibodies in an individual's blood can indicate a current or past infection with one of these viruses.

It is important to note that the presence of deltaretrovirus antibodies does not necessarily mean that the person has symptoms or will develop disease related to the virus. Some people with deltaretrovirus antibodies may never develop symptoms, while others may develop serious illnesses such as adult T-cell leukemia/lymphoma (HTLV-1) or neurological disorders (HTLV-1 associated myelopathy/tropical spastic paraparesis).

If you suspect that you may have been exposed to a deltaretrovirus, it is important to speak with your healthcare provider for further evaluation and testing.

I'm sorry for any confusion, but "Jamaica" is not a medical term. It is a country located in the Caribbean Sea, known for its beautiful beaches, vibrant culture, and as the birthplace of reggae music. If you have any questions about medical terms or concepts, I would be happy to help answer those!

Human T-lymphotropic virus 1 (HTLV-1) is a complex retrovirus that infects CD4+ T lymphocytes and can cause adult T-cell leukemia/lymphoma (ATLL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). The virus is primarily transmitted through breastfeeding, sexual contact, or contaminated blood products. After infection, the virus integrates into the host's genome and can remain latent for years or even decades before leading to disease. HTLV-1 is endemic in certain regions of the world, including Japan, the Caribbean, Central and South America, and parts of Africa.

Human T-lymphotropic virus 2 (HTLV-2) is a retrovirus that primarily infects CD4+ T lymphocytes and other cells of the immune system. It is a deltaretrovirus closely related to HTLV-1, but with distinct biological properties and geographic distribution.

HTLV-2 infection is usually asymptomatic, although some individuals may develop neurological or skin disorders. However, the association between HTLV-2 and these diseases is not as clear as it is for HTLV-1 and adult T-cell leukemia/lymphoma or tropical spastic paraparesis/HTLV-1 associated myelopathy (TSP/HAM).

HTLV-2 is primarily transmitted through breastfeeding, sexual contact, and sharing of needles among injecting drug users. It is endemic in certain populations, particularly indigenous communities in the Americas, such as the Guaraní and Kayapó in Brazil, and the Navajo and Pima in the United States. Prevalence rates can reach up to 30% in some of these populations.

There is currently no vaccine or specific treatment for HTLV-2 infection, and prevention efforts focus on reducing transmission risks through education and harm reduction strategies.

Deltaretroviruses are a genus of retroviruses that can cause chronic infections in humans and animals. The two main deltaretroviruses that infect humans are the Human T-cell Leukemia Virus type 1 (HTLV-1) and Human T-cell Leukemia Virus type 2 (HTLV-2).

HTLV-1 is primarily transmitted through breastfeeding, sexual contact, and contaminated blood products. It can cause several diseases, including Adult T-cell Leukemia/Lymphoma (ATLL) and a neurological disorder called HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).

HTLV-2 is primarily transmitted through intravenous drug use and sexual contact. While it has been associated with some diseases, such as neurological disorders and rare cases of leukemia, the link between HTLV-2 and disease is not as clear as it is for HTLV-1.

Deltaretrovirus infections can be diagnosed through blood tests that detect antibodies to the viruses or through genetic testing to detect the virus itself. There is currently no cure for deltaretrovirus infections, but antiretroviral therapy (ART) may help manage the infection and reduce the risk of transmission.

It's important to note that deltaretrovirus infections are relatively rare, and most people who are infected do not develop symptoms or disease. However, if you believe you may have been exposed to these viruses, it is important to speak with a healthcare provider for further evaluation and testing.

Deltaretroviruses are a genus of retroviruses that include human T-lymphotropic virus (HTLV) types 1 and 2, bovine leukemia virus (BLV), and simian T-lymphotropic viruses. These viruses are characterized by their ability to cause persistent infections and can lead to the development of various diseases such as adult T-cell leukemia/lymphoma (ATLL) and tropical spastic paraparesis/HTLV-associated myelopathy (TSP/HAM).

The genome of deltaretroviruses contains two copies of single-stranded RNA, which are reverse transcribed into double-stranded DNA during the replication process. The viral DNA is then integrated into the host cell's genome, leading to a lifelong infection.

Deltaretroviruses primarily infect CD4+ T cells and other immune cells, and transmission typically occurs through bodily fluids such as breast milk, blood, and sexual contact. Prevention measures include avoiding high-risk behaviors, screening blood products, and implementing strict infection control practices in healthcare settings.

I'm sorry for any confusion, but there seems to be no established medical definition for "Human T-lymphotropic virus 3" (HTLV-3). So far, only three types of Human T-lymphotropic viruses have been officially recognized and classified by the International Committee on Taxonomy of Viruses (ICTV). These are HTLV-1, HTLV-2, and HTLV-3/HTLV-4 provisional. The proposed HTLV-3 and HTLV-4 were identified in a few cameroonian hunters and not widely found in humans yet. Therefore, it's crucial to rely on validated and widely accepted sources when researching medical definitions and information.

Simian T-lymphotropic virus 1 (STLV-1) is a retrovirus that primarily infects Asian monkeys and apes. It is closely related to the human T-lymphotropic virus type 1 (HTLV-1), and there is evidence to suggest that STLV-1 may have been transmitted to humans through close contact with infected non-human primates, resulting in the emergence of HTLV-1.

Like HTLV-1, STLV-1 primarily infects CD4+ T lymphocytes and can cause a persistent infection. However, unlike HTLV-1, which is associated with several diseases including adult T-cell leukemia/lymphoma and tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM), STLV-1 has not been definitively linked to any specific human diseases.

STLV-1 infection is typically asymptomatic in both monkeys and humans, but it can cause a range of clinical manifestations in some individuals, including lymphadenopathy, hepatitis, and neurological symptoms. The virus is primarily transmitted through contact with infected bodily fluids, such as blood, breast milk, and semen.

Research on STLV-1 is important for understanding the evolution and epidemiology of retroviruses, as well as for developing strategies to prevent transmission and manage related diseases in both humans and non-human primates.

I'm sorry for the confusion, but "pX" is not a standard term in genetics or genomic medicine. It may be a typo or a specific shorthand used in certain contexts. If you could provide more context or clarify what "pX" is intended to represent, I would be happy to help further.

In general, genes are segments of DNA that contain the instructions for making proteins or RNA molecules. These instructions are encoded in a genetic alphabet consisting of four nucleotide bases: adenine (A), guanine (G), cytosine (C), and thymine (T). The sequence of these bases determines the genetic information within a gene, which can vary among individuals and contribute to differences in traits and disease susceptibility.

Primate T-lymphotropic virus 3 (PTLV-3) is not a widely recognized or established medical term. However, it's possible that you are referring to Primate T-cell Leukemia Virus type 3 (PTLV-3), which is a retrovirus that primarily infects non-human primates. It is closely related to the human T-lymphotropic virus type 1 and 2 (HTLV-1 and HTLV-2). PTLV-3, like other T-cell leukemia viruses, has been associated with the development of certain types of cancer, particularly adult T-cell leukemia/lymphoma (ATLL) in its natural host species. However, there is no known human infection with PTLV-3 to date.

A blood donor is a person who voluntarily gives their own blood or blood components to be used for the benefit of another person in need. The blood donation process involves collecting the donor's blood, testing it for infectious diseases, and then storing it until it is needed by a patient. There are several types of blood donations, including:

1. Whole blood donation: This is the most common type of blood donation, where a donor gives one unit (about 450-500 milliliters) of whole blood. The blood is then separated into its components (red cells, plasma, and platelets) for transfusion to patients with different needs.
2. Double red cell donation: In this type of donation, the donor's blood is collected using a special machine that separates two units of red cells from the whole blood. The remaining plasma and platelets are returned to the donor during the donation process. This type of donation can be done every 112 days.
3. Platelet donation: A donor's blood is collected using a special machine that separates platelets from the whole blood. The red cells and plasma are then returned to the donor during the donation process. This type of donation can be done every seven days, up to 24 times a year.
4. Plasma donation: A donor's blood is collected using a special machine that separates plasma from the whole blood. The red cells and platelets are then returned to the donor during the donation process. This type of donation can be done every 28 days, up to 13 times a year.

Blood donors must meet certain eligibility criteria, such as being in good health, aged between 18 and 65 (in some countries, the upper age limit may vary), and weighing over 50 kg (110 lbs). Donors are also required to answer medical questionnaires and undergo a mini-physical examination before each donation. The frequency of blood donations varies depending on the type of donation and the donor's health status.

A gene product is the biochemical material, such as a protein or RNA, that is produced by the expression of a gene. Gene products are the result of the translation and transcription of genetic information encoded in DNA or RNA.

In the context of "tax," this term is not typically used in a medical definition of gene products. However, it may refer to the concept of taxing or regulating gene products in the context of genetic engineering or synthetic biology. This could involve imposing fees or restrictions on the production, use, or sale of certain gene products, particularly those that are genetically modified or engineered. The regulation of gene products is an important aspect of ensuring their safe and effective use in various applications, including medical treatments, agricultural production, and industrial processes.

Retroviridae infections refer to diseases caused by retroviruses, which are a type of virus that integrates its genetic material into the DNA of the host cell. This allows the virus to co-opt the cell's own machinery to produce new viral particles and infect other cells.

Some well-known retroviruses include human immunodeficiency virus (HIV), which causes AIDS, and human T-lymphotropic virus (HTLV), which can cause certain types of cancer and neurological disorders.

Retroviral infections can have a range of clinical manifestations depending on the specific virus and the host's immune response. HIV infection, for example, is characterized by progressive immunodeficiency that makes the infected individual susceptible to a wide range of opportunistic infections and cancers. HTLV infection, on the other hand, can cause adult T-cell leukemia/lymphoma or tropical spastic paraparesis, a neurological disorder.

Prevention and treatment strategies for retroviral infections depend on the specific virus but may include antiretroviral therapy (ART), vaccination, and behavioral modifications to reduce transmission risk.

Retroviridae is a family of viruses that includes human immunodeficiency virus (HIV) and other viruses that primarily use RNA as their genetic material. The name "retrovirus" comes from the fact that these viruses reverse transcribe their RNA genome into DNA, which then becomes integrated into the host cell's genome. This is a unique characteristic of retroviruses, as most other viruses use DNA as their genetic material.

Retroviruses can cause a variety of diseases in animals and humans, including cancer, neurological disorders, and immunodeficiency syndromes like AIDS. They have a lipid membrane envelope that contains glycoprotein spikes, which allow them to attach to and enter host cells. Once inside the host cell, the viral RNA is reverse transcribed into DNA by the enzyme reverse transcriptase, which is then integrated into the host genome by the enzyme integrase.

Retroviruses can remain dormant in the host genome for extended periods of time, and may be reactivated under certain conditions to produce new viral particles. This ability to integrate into the host genome has also made retroviruses useful tools in molecular biology, where they are used as vectors for gene therapy and other genetic manipulations.

A gene product is the biochemical material, such as a protein or RNA, that is produced by the expression of a gene. Env, short for "envelope," refers to a type of gene product that is commonly found in enveloped viruses. The env gene encodes the viral envelope proteins, which are crucial for the virus's ability to attach to and enter host cells during infection. These envelope proteins typically form a coat around the exterior of the virus and interact with receptors on the surface of the host cell, triggering the fusion or endocytosis processes that allow the viral genome to enter the host cell.

Therefore, in medical terms, 'Gene Products, env' specifically refers to the proteins or RNA produced by the env gene in enveloped viruses, which play a critical role in the virus's infectivity and pathogenesis.

I'm not aware of any medical condition or term that is specifically associated with or referred to as "Cameroon." Cameroon is a country located in Central Africa, known for its rich biodiversity and cultural diversity. If you have more context about why you are looking for a medical definition of "Cameroon," I may be able to provide a more helpful response.

"Cercocebus" is a genus of Old World monkeys that includes several species, such as the sooty mangabey and the gray-cheeked mangabey. These monkeys are native to central Africa and are known for their distinctive appearance, with a long tail, dark fur, and light cheek whiskers. They are omnivorous and live in social groups. The name "Cercocebus" comes from the Greek words "kerkos," meaning tail, and "kephale," meaning head, referring to their long tails.

I'm not aware of a specific medical term called "Ape diseases." However, many primates, including apes, can suffer from diseases that are similar to those that affect humans. Some examples include:

1. Tuberculosis (TB): Both humans and apes can be infected with this bacterial disease, which primarily affects the lungs but can also impact other parts of the body.
2. Hepatitis: Apes can contract various forms of hepatitis, such as hepatitis B and C, just like humans. These viral infections affect the liver and can cause acute or chronic illness.
3. Respiratory infections: Both apes and humans are susceptible to respiratory infections caused by bacteria, viruses, or fungi.
4. Gastrointestinal diseases: Apes can suffer from gastrointestinal issues, such as diarrhea, due to various bacterial, viral, or parasitic infections.
5. Retroviral infections: Some apes are known to be infected with retroviruses, like simian immunodeficiency virus (SIV), which is similar to human immunodeficiency virus (HIV). SIV can lead to a condition called simian AIDS in apes.
6. Zoonotic diseases: Apes can contract zoonotic diseases, which are transmitted from animals to humans, such as Ebola and Marburg viruses.
7. Cardiovascular diseases: Apes can develop heart conditions similar to those seen in humans, including hypertension and atherosclerosis.
8. Neurological disorders: Some apes may suffer from neurological issues, like Parkinson's disease or Alzheimer's disease, although research on these topics is still ongoing.

It's important to note that while apes can contract many of the same diseases as humans, there are also numerous diseases specific to each species due to differences in genetics, environment, and behavior.

Collagen diseases, also known as collagen disorders or connective tissue diseases, refer to a group of medical conditions that affect the body's connective tissues. These tissues provide support and structure for various organs and systems in the body, including the skin, joints, muscles, and blood vessels.

Collagen is a major component of connective tissues, and it plays a crucial role in maintaining their strength and elasticity. In collagen diseases, the body's immune system mistakenly attacks healthy collagen, leading to inflammation, pain, and damage to the affected tissues.

There are several types of collagen diseases, including:

1. Systemic Lupus Erythematosus (SLE): This is a chronic autoimmune disease that can affect various organs and systems in the body, including the skin, joints, kidneys, heart, and lungs.
2. Rheumatoid Arthritis (RA): This is a chronic inflammatory disease that primarily affects the joints, causing pain, swelling, and stiffness.
3. Scleroderma: This is a rare autoimmune disorder that causes thickening and hardening of the skin and connective tissues, leading to restricted movement and organ damage.
4. Dermatomyositis: This is an inflammatory muscle disease that can also affect the skin, causing rashes and weakness.
5. Mixed Connective Tissue Disease (MCTD): This is a rare autoimmune disorder that combines symptoms of several collagen diseases, including SLE, RA, scleroderma, and dermatomyositis.

The exact cause of collagen diseases is not fully understood, but they are believed to be related to genetic, environmental, and hormonal factors. Treatment typically involves a combination of medications, lifestyle changes, and physical therapy to manage symptoms and prevent complications.

Leukemia is a type of cancer that originates from the bone marrow - the soft, inner part of certain bones where new blood cells are made. It is characterized by an abnormal production of white blood cells, known as leukocytes or blasts. These abnormal cells accumulate in the bone marrow and interfere with the production of normal blood cells, leading to a decrease in red blood cells (anemia), platelets (thrombocytopenia), and healthy white blood cells (leukopenia).

There are several types of leukemia, classified based on the specific type of white blood cell affected and the speed at which the disease progresses:

1. Acute Leukemias - These types of leukemia progress rapidly, with symptoms developing over a few weeks or months. They involve the rapid growth and accumulation of immature, nonfunctional white blood cells (blasts) in the bone marrow and peripheral blood. The two main categories are:
- Acute Lymphoblastic Leukemia (ALL) - Originates from lymphoid progenitor cells, primarily affecting children but can also occur in adults.
- Acute Myeloid Leukemia (AML) - Develops from myeloid progenitor cells and is more common in older adults.

2. Chronic Leukemias - These types of leukemia progress slowly, with symptoms developing over a period of months to years. They involve the production of relatively mature, but still abnormal, white blood cells that can accumulate in large numbers in the bone marrow and peripheral blood. The two main categories are:
- Chronic Lymphocytic Leukemia (CLL) - Affects B-lymphocytes and is more common in older adults.
- Chronic Myeloid Leukemia (CML) - Originates from myeloid progenitor cells, characterized by the presence of a specific genetic abnormality called the Philadelphia chromosome. It can occur at any age but is more common in middle-aged and older adults.

Treatment options for leukemia depend on the type, stage, and individual patient factors. Treatments may include chemotherapy, targeted therapy, immunotherapy, stem cell transplantation, or a combination of these approaches.

Retroviridae proteins, oncogenic, refer to the proteins expressed by retroviruses that have the ability to transform normal cells into cancerous ones. These oncogenic proteins are typically encoded by viral genes known as "oncogenes," which are acquired through the process of transduction from the host cell's DNA during retroviral replication.

The most well-known example of an oncogenic retrovirus is the Human T-cell Leukemia Virus Type 1 (HTLV-1), which encodes the Tax and HBZ oncoproteins. These proteins manipulate various cellular signaling pathways, leading to uncontrolled cell growth and malignant transformation.

It is important to note that not all retroviruses are oncogenic, and only a small subset of them have been associated with cancer development in humans or animals.

Cell transformation, viral refers to the process by which a virus causes normal cells to become cancerous or tumorigenic. This occurs when the genetic material of the virus integrates into the DNA of the host cell and alters its regulation, leading to uncontrolled cell growth and division. Some viruses known to cause cell transformation include human papillomavirus (HPV), hepatitis B virus (HBV), and certain types of herpesviruses.

Seroepidemiologic studies are a type of epidemiological study that measures the presence and levels of antibodies in a population's blood serum to investigate the prevalence, distribution, and transmission of infectious diseases. These studies help to identify patterns of infection and immunity within a population, which can inform public health policies and interventions.

Seroepidemiologic studies typically involve collecting blood samples from a representative sample of individuals in a population and testing them for the presence of antibodies against specific pathogens. The results are then analyzed to estimate the prevalence of infection and immunity within the population, as well as any factors associated with increased or decreased risk of infection.

These studies can provide valuable insights into the spread of infectious diseases, including emerging and re-emerging infections, and help to monitor the effectiveness of vaccination programs. Additionally, seroepidemiologic studies can also be used to investigate the transmission dynamics of infectious agents, such as identifying sources of infection or tracking the spread of antibiotic resistance.

A Radioimmunoprecipitation Assay (RIA) is a highly sensitive laboratory technique used to measure the presence and concentration of specific antigens or antibodies in a sample. This technique combines the use of radioisotopes, immunochemistry, and precipitation reactions.

In an RIA, a known quantity of a radioactively labeled antigen (or hapten) is incubated with a sample containing an unknown amount of antibody (or vice versa). If the specific antigen-antibody pair is present in the sample, they will bind together to form an immune complex. This complex can then be selectively precipitated from the solution using a second antibody that recognizes and binds to the first antibody, thus forming an insoluble immune precipitate.

The amount of radioactivity present in the precipitate is directly proportional to the concentration of antigen or antibody in the sample. By comparing this value to a standard curve generated with known concentrations of antigen or antibody, the unknown concentration can be accurately determined. RIAs have been widely used in research and clinical settings for the quantification of various hormones, drugs, vitamins, and other biomolecules. However, due to safety concerns and regulatory restrictions associated with radioisotopes, non-radioactive alternatives like Enzyme-Linked Immunosorbent Assays (ELISAs) have become more popular in recent years.

Tropical spastic paraparesis (TSP) is a type of myelopathy (spinal cord disorder) that is associated with chronic infectious or inflammatory conditions. The term "paraparesis" refers to partial weakness in the lower extremities, which is a characteristic feature of TSP.

In Tropical spastic paraparesis, there is a slow and progressive degeneration of the spinal cord, leading to symptoms such as muscle weakness, stiffness, and spasticity (involuntary muscle contractions) in the legs. Other common symptoms include sensory loss, bladder and bowel dysfunction, and sexual impairment.

TSP is often caused by a chronic infection with the human T-lymphotropic virus type 1 (HTLV-1), which is endemic in certain tropical and subtropical regions, including the Caribbean, South America, Central America, Africa, and parts of Asia. The virus is transmitted through blood transfusions, sexual contact, and breastfeeding.

There is no cure for TSP, but symptoms can be managed with physical therapy, medications to relieve muscle spasticity, and other supportive measures. It is important to diagnose and treat TSP early to prevent or slow down the progression of the disease and improve quality of life.

Mycosis fungoides is the most common type of cutaneous T-cell lymphoma (CTCL), a rare cancer that affects the skin's immune system. It is characterized by the infiltration of malignant CD4+ T-lymphocytes into the skin, leading to the formation of patches, plaques, and tumors. The disease typically progresses slowly over many years, often starting with scaly, itchy rashes that can be mistaken for eczema or psoriasis. As the disease advances, tumors may form, and the lymphoma may spread to other organs, such as the lymph nodes, lungs, or spleen. Mycosis fungoides is not contagious and cannot be spread from person to person. The exact cause of mycosis fungoides is unknown, but it is thought to result from a combination of genetic, environmental, and immune system factors.

T-lymphocytes, also known as T-cells, are a type of white blood cell that plays a key role in the adaptive immune system's response to infection. They are produced in the bone marrow and mature in the thymus gland. There are several different types of T-cells, including CD4+ helper T-cells, CD8+ cytotoxic T-cells, and regulatory T-cells (Tregs).

CD4+ helper T-cells assist in activating other immune cells, such as B-lymphocytes and macrophages. They also produce cytokines, which are signaling molecules that help coordinate the immune response. CD8+ cytotoxic T-cells directly kill infected cells by releasing toxic substances. Regulatory T-cells help maintain immune tolerance and prevent autoimmune diseases by suppressing the activity of other immune cells.

T-lymphocytes are important in the immune response to viral infections, cancer, and other diseases. Dysfunction or depletion of T-cells can lead to immunodeficiency and increased susceptibility to infections. On the other hand, an overactive T-cell response can contribute to autoimmune diseases and chronic inflammation.

Retroviridae is a family of viruses that includes HIV (Human Immunodeficiency Virus). Retroviridae proteins refer to the various structural and functional proteins that are encoded by the retroviral genome. These proteins can be categorized into three main groups:

1. Group-specific antigen (Gag) proteins: These proteins make up the viral matrix, capsid, and nucleocapsid. They are involved in the assembly of new virus particles.

2. Polymerase (Pol) proteins: These proteins include the reverse transcriptase, integrase, and protease enzymes. Reverse transcriptase is responsible for converting the viral RNA genome into DNA, which can then be integrated into the host cell's genome by the integrase enzyme. The protease enzyme is involved in processing the polyprotein precursors of Gag and Pol into their mature forms.

3. Envelope (Env) proteins: These proteins are responsible for the attachment and fusion of the virus to the host cell membrane. They are synthesized as a precursor protein, which is then cleaved by a host cell protease to form two distinct proteins - the surface unit (SU) and the transmembrane unit (TM). The SU protein contains the receptor-binding domain, while the TM protein forms the transmembrane anchor.

Retroviral proteins play crucial roles in various stages of the viral life cycle, including entry, reverse transcription, integration, transcription, translation, assembly, and release. Understanding the functions of these proteins is essential for developing effective antiretroviral therapies and vaccines against retroviral infections.

Lymphoma is a type of cancer that originates from the white blood cells called lymphocytes, which are part of the immune system. These cells are found in various parts of the body such as the lymph nodes, spleen, bone marrow, and other organs. Lymphoma can be classified into two main types: Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL).

HL is characterized by the presence of a specific type of abnormal lymphocyte called Reed-Sternberg cells, while NHL includes a diverse group of lymphomas that lack these cells. The symptoms of lymphoma may include swollen lymph nodes, fever, night sweats, weight loss, and fatigue.

The exact cause of lymphoma is not known, but it is believed to result from genetic mutations in the lymphocytes that lead to uncontrolled cell growth and division. Exposure to certain viruses, chemicals, and radiation may increase the risk of developing lymphoma. Treatment options for lymphoma depend on various factors such as the type and stage of the disease, age, and overall health of the patient. Common treatments include chemotherapy, radiation therapy, immunotherapy, and stem cell transplantation.

There is no single medical definition for "Monkey Diseases." However, monkeys can carry and be infected with various diseases that are zoonotic, meaning they can be transmitted from animals to humans. Some examples include:

1. Simian Immunodeficiency Virus (SIV): A virus similar to Human Immunodeficiency Virus (HIV) that causes AIDS in monkeys. It is not typically harmful to monkeys but can cause AIDS in humans if transmitted, which is rare.
2. Herpes B Virus: Also known as Macacine herpesvirus 1 or Cercopithecine herpesvirus 1, it is a virus that commonly infects macaque monkeys. It can be transmitted to humans through direct contact with an infected monkey's saliva, eye fluid, or cerebrospinal fluid, causing a severe and potentially fatal illness called B encephalitis.
3. Tuberculosis (TB): Monkeys can contract and transmit tuberculosis to humans, although it is not common.
4. Simian Retrovirus (SRV): A virus that can infect both monkeys and great apes, causing immunodeficiency similar to HIV/AIDS in humans. It is not known to infect or cause disease in humans.
5. Various parasitic diseases: Monkeys can carry and transmit several parasites, including malaria-causing Plasmodium species, intestinal worms, and other parasites that can affect human health.

It's important to note that while monkeys can carry and transmit these diseases, the risk of transmission is generally low, and most cases occur in individuals who have close contact with monkeys, such as primatologists, zookeepers, or laboratory workers. Always follow safety guidelines when interacting with animals, including monkeys, to minimize the risk of disease transmission.